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Pulse oximetryAbstract Background and objectives: Cardiovascular malformations are the commonest form of
congenital defects and could result in significant morbidity. Antenatal and early postnatal detection
is still unreliable, especially in developing countries and low-income communities. The aim of the
study was to assess the value of early pulse oximetry in the detection of cardiac lesions among
asymptomatic term newborns with subnormal oxygen saturation.
Patients and methods: A cross-sectional study was conducted at the well-baby nursery of a commu-
nity hospital, between March and August 2013. A total of 120 asymptomatic, apparently healthy
term newborns who had persistent postductal SpO2 < 95% in the initial and repeat tests within
the first 24 h after birth were consecutively enrolled. Pulse oximetry testing was performed after
the age of 2 h and confirmed 2 h later. Cases with persistent saturation below 95% underwent
echocardiography.
Results: Significant cardiac lesions were detected in 38 newborns (31.6%); they had significantly
lower oxygen saturation compared to those with insignificant lesions (n= 41, 34.2%) and normal
hearts (n= 41, 34.2%). Repeat testing after 2 h was more reliable. Using cut-offs lower than 95%
missed a significant number of lesions.
Conclusion: Pulse oximetry can be used as a tool in apparently healthy term newborns for the early
detection of cardiac lesions that might necessitate specialized follow-up and care. An initial test
after the age of 2 h followed by a confirmatory test 2 h later, with a cut-off value of <95% is
proposed. A comprehensive study is necessary to validate the results of this study. This might be
of significant importance in low-income communities.
 2016 The Egyptian Pediatric Association. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).eet, El
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Apparently healthy newborn babies may be admitted to the
nursery with hidden malformations or an unrecognized dis-
ease. Despite looking pink to health workers observing them,
the baby might have low arterial oxygen saturation; a sign of
a disease.1,2
Cardiovascular malformations are the commonest type of
congenital malformations.3–5 The term congenital heart defects
(CHDs) encompasses a variety of lesions with a wide spectrum
of clinical significance, ranging from hemodynamically-
insignificant to potentially significant lesions,4 and hypoxemia
is a common feature of many forms of CHD.6
Screening strategies to detect CHDs rely on antenatal ultra-
sound and postnatal clinical examination; however, both tech-
niques have a fairly low detection rate for isolated defects and
many babies are discharged from hospital without diagnosis.7
Significant progress in the care of CHD patients has been
observed, mostly due to improvements in diagnostic, medical,
interventional and surgical management. However, no remark-
able change in the detection of CHD in newborns has been
noted.8 Therefore the progress of screening strategies to
enhance early detection is of great importance,6,7 especially
with the current tendency toward early postpartum discharge.8
Pulse oximetry (POx) is a noninvasive, quick, simple, safe
and painless test that measures oxygen saturation (SpO2),
and adds value to the existing screening.7,9–11 It does not
require calibration and is able to provide instantaneous data
that correlate well with blood gas measurements.6 Thus, it
may allow the early detection of hypoxemia that would not
necessarily produce clinical cyanosis in initially asymptomatic
lesions.5
The first hour of life is not suitable for POx testing owing
to the large number of false findings.12,13 Thereafter, infants
can be examined at any time, but somewhat more reliably
after 2 h.12,14 Concurrently, it is challenging to set the cut-
off value for a positive test. Based on several studies,5,8,12,14
it has been recommended to use a SpO2 value <95% in the
lower limb.15
Pure left-to-right shunts such as ventricular septal defect
(VSD), atrial septal defect (ASD), or patent ductus arteriosus
(PDA) do not produce arterial desaturation, but some of these
defects proved to be test-positive. This happened almost at all
times within the first 24 h of life, probably due to bidirectional
or right-to-left shunting during early postnatal transition.5,12,16
Occasionally, shunting may occur at more than one level.12
In developing countries, many challenges oppose the man-
agement of CHDs, including early diagnosis, team approach,
referral systems, medical insurance, limited resources, and
availability of state-of-the-art pediatric cardiac centers.
Research to date in low-income countries has mainly prior-
itized the role of pulse oximetry in sick newborns and not in
apparently healthy newborns. Meanwhile, there is no primary
data on the prevalence of hypoxemia in asymptomatic new-
borns.17 Currently in Egypt, pulse oximetry is not routinely
applied in all maternity units especially in low-income
communities.
The aim of the present study was to assess the value of early
pulse oximetry in the detection of cardiac lesions among
asymptomatic term newborns with subnormal oxygen
saturation.Patients and methods
Study design
This was a cross-sectional study conducted at Bab-El-Shaeria
Hospital, Al-Azhar University, Cairo, Egypt, over a period
of 6 months from March to August 2013. The study was
approved by the local Ethics Committee. Informed parental
consent was obtained prior to enrollment in the study.
Study population
The study included all consecutive candidates born and
admitted to the well-baby nursery fulfilling the eligibility
criteria. Asymptomatic, apparently-well babies delivered at
term (37–40 completed weeks of gestation) who had persistent
postductal SpO2 < 95% in the initial and repeat tests within
the first 24 h after birth, irrespective of the mode of delivery
were included. Exclusion criteria included: preterm newborns,
symptomatic newborns with cardiovascular instability or cya-
nosis, newborns with a cardiac murmur, respiratory distress or
any other condition necessitating monitoring or admission to
NICU or might cause desaturation, dysmorphic features or
suspected to have clinical syndromes, a positive antenatal his-
tory, and an antenatal diagnosis of CHD or maternal history
of PROM.
Methods
Pulse oximetry measurement was performed when the babies
were awake, calm, fed and with normal temperature at the
nursery between 2nd and 24th hours, using portable pulse
oximetry (Huntleigh, smart signs, mini pulse, MP1 standard,
Huntleigh Healthcare Ltd, UK) which displays fractional oxy-
gen saturation and pulse rate. The probe was placed on the
right foot for at least 2 min until a stable recording was
obtained. After each measurement, the multiple-use sensor
was disinfected.
If the initial SpO2 < 95%, POx test was repeated 2 h later.
Newborns with persistent SpO2 < 95% in the repeat test were
subjected to thorough history taking and complete clinical
evaluation by trained personnel; and underwent
echocardiography.
Echocardiographic examination was performed by a single
operator using GE Vivid 7 Dimension echocardiography
machine (GE Medical System, N-3190, Horten, Norway), in
standardized views (subcostal, apical, left parasternal and
suprasternal), utilizing the two dimensional (2-D), color flow
Doppler, continuous wave (CW), pulsed wave (PW) and
motion-mode (M-mode).
Congenital heart disease was defined as ‘‘the presence of a
gross structural abnormality of the heart or intrathoracic great
vessels that is actually or potentially of functional signifi-
cance”.18 Thus, isolated abnormalities of no functional conse-
quence (such as persistent left superior vena cava), congenital
arrhythmias and abnormalities of the transitional circulation
and physiologic pulmonary branch stenosis, were not consid-
ered to be indicative of CHD.5
Based on the significance of echocardiographic findings,
studied cases were categorized into 3 groups: significant
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II), and normal intracardiac anatomy (group III). Cases asso-
ciated with a significant cardiac lesion were considered as
‘‘true-positive”, while those associated with insignificant car-
diac lesions or with normal intracardiac anatomy were consid-
ered as ‘‘false-positive”.
Statistical analysis
Data were analyzed using IBM SPSS Advanced Statistics
version 22.0 (IBM Corp., Armonk, NY, USA). Numerical
data were expressed as mean, standard deviation, and range.
Qualitative data were expressed as frequency and percentage.
Chi-square test was used to examine the relation between the
qualitative variables. For quantitative data, comparison
between 2 groups was done using independent sample t-test.
Comparison between 3 groups was done using ANOVA test,
followed by post-hoc ‘‘Scheffe test” for pairwise comparisons.
p-Value <0.05 was considered statistically significant.Table 1 Echocardiographic findings of the studied groups
(n= 120).
Groups Number %
Group I: significant cardiac lesions 38 31.6
PDA± PFO 25a 20.8
PDA, PFO, pulmonary hypertension 5 4.2
PDA, PFO, VSD 5 4.2
PDA, PFO, secundum ASD 1 0.8
PDA, TR, MR 1 0.8
PA, PDA, PFO, severe TR 1 0.8
Group II: insignificant cardiac lesions 41 34.2
Tiny PDA± PFO 17b 14.2
PFO 23 19.2
Mild TR 1 0.8
Group III: normal intracardiac anatomy 41 34.2
PDA, patent ductus arteriosus; VSD, ventricular septal defect;
ASD, atrial septal defect; PFO, patent foramen ovale; TR, tricuspid
regurgitation; MR, mitral regurgitation; PA, pulmonary atresia.
a Isolated PDA in 3 cases.
b Isolated tiny PDA in 3 cases.
Table 2 Demographic and clinical characteristics of the studied gro
Variable Group I (n= 38) G
Gender (male/female) 19/19 19
Mode of delivery (NVD/CS) 13/25 11
Gestational age (weeks) 38.2 ± 0.8 38
Maternal age (years) 28.8 ± 5.7 28
Birth weight (kg) 3.17 ± 0.28 3.
Length (cm) 49.3 ± 0.9 49
Head circumference (cm) 34.9 ± 0.9 35
Respiratory rate/min 45.0 ± 2.0 44
Heart rate (bpm) 133.0 ± 6.0 13
Temperature (C) 36.79 ± 0.15 36
Data are expressed as ratio or mean ± standard deviation.
Analysis by: yChi-square test; one-way ANOVA.
NVD, normal vaginal delivery; CS, cesarean section.Results
On analyzing the characteristics of 120 candidates fulfilling the
eligibility criteria, the mean postnatal age of initial POx testing
was 3.3 ± 1.1 h (range: 2.5–13.0 h); their gestational age ran-
ged from 37 to 40 completed weeks with a mean of 38.2
± 0.8 weeks. 55.0% were males and 45.0% were females;
68.3% were delivered by cesarean section and 31.7% vaginally.
All had negative family history and the mean maternal age was
28.7 ± 4.8 years. The mean birth weight, length and head cir-
cumference were 3.19 ± 0.29 kg, 49.0 ± 1.1 cm, and 35.0
± 0.9 cm, respectively. At the initial test, the mean respiratory
rate was 45.0 ± 2.0/min, heart rate was 133 ± 7 bpm, and
temperature was 36.81 ± 0.14 C. The postductal mean SpO2
value was 92 ± 1% (range: 88–94%) and 93 ± 1% (range:
91–94%) at the initial and repeat tests, respectively.
Table 1 summarizes the echocardiographic findings of the
studied groups. Group I had significant lesions that needed
clinical follow-up and/or intervention (n= 38, 31.6%)
including significant PDAP 2.0 mm in diameter (mean of
2.29 ± 0.56 mm, ranging from 2.0 to 5.0 mm with a median
of 2.27 mm), VSDs (P 3 mm), secundum ASD (> 5 mm),
and valvular regurgitations exceeding the normal mild range.
Also, one case with critical significant lesions in the form of
pulmonary atresia, duct dependent pulmonary circulation,
with PFO and severe tricuspid regurgitation was detected.
Group II had hemodynamically-insignificant lesions that are
expected to resolve (n= 41, 34.2%). These included tiny
PDA (< 2.0 mm), patent foramen ovale (PFO), and mild
valvular regurgitation. Group III included those who had nor-
mal intracardiac anatomy (n= 41, 34.2%).
The demographic and clinical characteristics of the studied
groups are presented in Table 2. The gestational age, gender,
mode of delivery, maternal age, birth weight, length, head cir-
cumference, respiratory rate, heart rate and temperature
showed statistically non-significant difference among the 3
studied groups (p> 0.05).
POx results of the studied groups are demonstrated in
Table 3. The three groups were comparable in postnatal age
at the initial POx test (p= 0.544). The initial and repeat
SpO2 values showed a significant difference between the 3
groups (p-values <0.001). On the initial test, SpO2 was signif-
icantly lower in groups I and II compared to group IIIups (n= 120).
roup II (n= 41) Group III (n= 41) p Value
/22 28/13 0.110y
/30 14/27 0.801y
.3 ± 0.9 38.1 ± 0.7 0.591
.5 ± 3.5 28.8 ± 5.0 0.948
19 ± 0.29 3.21 ± 0.28 0.822
.5 ± 1.1 49.9 ± 1.1 0.070
.0 ± 1.0 35.0 ± 1.0 0.890
.0 ± 3.0 44.0 ± 2.0 0.450
3.0 ± 8.0 134 ± 8.0 0.854
.81 ± 0.14 36.84 ± 0.14 0.316
Table 3 Pulse oximetry results of the studied groups (n= 120).
Variable Group I (n= 38) Group II (n= 41) Group III (n= 41) p Value
Age at POx-1 (h) 3.2 ± 0.6 3.4 ± 1.6 3.3 ± 0.7 0.544
(2.5–5.0) (2.5–13.0) (2.5–6.0)
POx-1 (SpO2%) 91 ± 1
a 92 ± 1a 93 ± 1b <0.001
(88–94)a (89–94)a (91–94)b
POx-2 (SpO2%) 93 ± 1
a 93 ± 1b 94 ± 1b <0.001
(91–94)a (91–94)b (92–94)b
Data are expressed as mean ± standard deviation and (range).
Analysis by: one-way ANOVA; post-hoc ‘‘Scheffe test”.
Groups with different superscript letters were significantly different.
POx-1, initial pulse oximetry; POx-2, repeat pulse oximetry; SpO2, pulse oximetry oxygen saturation.
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were comparable (p= 0.056). However on repeat testing,
SpO2 was significantly lower in group I compared to group
II (p= 0.012) and group III (p< 0.001) while groups II and
III were comparable (p= 0.115).
Further analysis of the total 120 cases using lower cut-off
values of <93% and <94%, revealed that 57.9% (22/38)
and 18.4% (7/38) of cases with significant cardiac lesions
(true-positive), respectively, will be missed.
Discussion
The study population of the present work was obtained from a
community hospital serving a large primarily indigent popula-
tion. Typically in this socio-economic community, antenatal
follow-up and routine care is not well-applied. This is also cou-
pled with early postpartum discharge and the absence of
proper well-baby routine follow-up. In such a setting, a simple,
quick, non-costly and readily-available tool for the early detec-
tion of possible cardiac defects is of importance.
This study looks at improving the detection of cardiac
lesions using pulse oximetry. The premise of the study is that
pulse oximetry, by detecting lower than normal postductal
oxygen saturation within the first 24 h of life, will alert the clin-
ician to the possibility of cardiac lesions in otherwise healthy
asymptomatic newborns. Therefore, this work targeted assess-
ing the value of early pulse oximetry in the detection of cardiac
lesions among asymptomatic term newborns with subnormal
oxygen saturation.
Among the studied cases, it was found that 31.6% of cases
had significant cardiac lesions (true-positive) that were referred
to the cardiology unit for specialized follow-up and care. One
case was detected with a critical cardiac lesion that necessitated
immediate intervention. The mild desaturation in cases with
cardiac defects in the absence of symptoms might be explained
in the light of transition from the in-parallel to the in-series cir-
culation after birth, which is partially dependent on the pres-
ence of residual cardiopulmonary shunts and available
oxygen,19 which is a higher detection rate than that stated by
other researchers.5,12
The false-positive rate was 68.4% which is higher than that
reported by Sattar et al.20 (55%) and Schelp et al.21 (43.8%).
Nevertheless, the false positive cases could carry some advan-
tage as also emphasized by other investigators, since it candraw attention to an underlying problem such as persistent
fetal circulation, which would benefit specialized medical care.5
The course of postnatal oxygen saturation has been studied
and its course is known: a healthy newborn has a mean satu-
ration of 73% at the age of 2 min that rises to 95% within
1 h. However, it is also pronounced that this process is widely
variable among individuals and a false-positive rate of POx
testing is high very early after birth,11–13,22 hence the choice
of timing, 2 h or more after birth for the initial test in this
study.12,14
On initial testing, both the significant and insignificant
groups were similar and showed a significant difference from
the normal group. However on repeat testing after 2 h, this
shifted to significantly lower saturation in the group with sig-
nificant lesions compared to the other two groups. Apart from
correlating with the clinical expectations that those with
insignificant lesions match with the normal subjects, it also
confirms that the initial POx test should be done no earlier
than 2 h postpartum, and also that a second confirmatory test
should be performed prior to requesting an echocardiogram.
The SpO2 cut-off of <95% seems to be valid as by testing
lower cut-offs of <93% and <94%, a considerable number of
cases with significant cardiac lesions will be missed. This is sup-
ported by many previous researchers who considered a SpO2
of <95%, as an appropriate threshold, at repeated measure-
ments to minimize missed cases.5,8,12,14,15,23,24
Moreover, Riede and colleagues,25 along with other
researchers5,12,22 have similarly concluded the usefulness of
pulse oximetry screening despite differences among the study
protocols concerning target lesions, time of screening, cut-off
values, probe placement and others.
The data of the present study would be of value and serve
as an initiative for the development of future studies to endorse
the utilization of pulse oximetry as a screening tool especially
in low-income communities.
Conclusion
Pulse oximetry can be used as a tool in apparently healthy term
newborns for the early detection of cardiac lesions that might
necessitate specialized follow-up and care. An initial test after
the age of 2 h followed by a confirmatory test 2 h later, with a
cut-off value of <95% is proposed. A comprehensive study is
required to validate the results of this study. This might be of
significant importance in low-income communities.
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